Richard Louis Dunbar MD
Assistant Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
39th and Market StreetsPhi Suite 2aPhiladelphia, PA 19104
Phone+1 215-662-9990
Fax+1 215-615-0500
Dr. Dunbar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1997 - 2000
Virginia Commonwealth University School of MedicineClass of 1997
Certifications & Licensure
PA State Medical License 2003 - 2026
VA State Medical License 1998 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study Start of enrollment: 2008 Jun 01
- Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Start of enrollment: 2009 Feb 01
- Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.Rahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton
Journal of the American Heart Association. 2025-03-04 - 6 citationsEstimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy.Maureen Sampson, Anna Wolska, Marcelo Amar, Masako Ueda, Richard Dunbar
Clinical Chemistry. 2022-10-06 - 30 citationsInhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe HypertriglyceridemiaZahid Ahmad, Robert Pordy, Daniel J. Rader, Daniel Gaudet, Shazia Ali
Journal of the American College of Cardiology. 2021-07-13
Press Mentions
Injectable Regeneron Biologic Therapy Reduces Triglycerides, CholesterolNovember 15th, 2016
Injectable Biologic Therapy Dramatically Reduces TriglyceridesNovember 14th, 2016
Grant Support
- Niacin'S Effect On Fatty Acids And Inflammatory Markers (Nefa-Im)National Heart, Lung, And Blood Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
